查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133471

全球輸液袋市場-2022-2029

Global IV Bags Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

輸液袋市場的增長是由癌症和神經系統疾病等各種疾病的患病率上升、越來越多地採用輸液療法來適當治療疾病、增加老年人口以及活動帶來的研究和開發推動的。

腸外營養療法的普及預計將推動市場增長

癌症和心血管疾病等各種疾病的患病率上升預計將在預測期內提振市場。根據世界衛生組織 2022 年數據報告，每年有 4100 萬人死於非傳染性疾病。這種疾病包括癌症、糖尿病等。在這種情況下，緊急情況下需要腸外營養。惡性腫瘤、缺血性腸病、胃腸道疾病、克羅恩病和糖尿病並發症等疾病的發病率不斷上升，這推動了人們對腸外營養的興趣。對腸外營養療法的需求不斷增長，正在推動全球輸液袋市場的發展。

此外，大公司正在應用他們的市場戰略，例如新產品發布和與其他市場參與者的合作。例如，2022 年 1 月，ICU Medical 從 Smiths Group plc 收購了 Smiths Medical，將 Smiths Medical 注射器和流動輸液設備、血管通路和重要護理產品添加到 ICU Medical 的產品組合中，打造了一家更強大、具有全球影響力的輸液治療領先公司得到了加強。同樣在 2021 年 3 月，Fagron Sterile Services (FSS) 通過推出一個新平台來擴展其產品組合，該平台具有多種可用於靜脈注射 (IV) 袋的展示。

輸液袋中化學物質的洗脫阻礙了市場增長

但是，PVC 袋並不適合所有人的產品，例如血液製品。輸液袋主要由聚氯乙烯（PVC）材料製成。由於 PVC 本質上是剛性的，因此添加增塑劑以獲得所需的性能。由於這些增塑劑沒有與 PVC 基體共價結合，因此它們很容易滲入周圍的溶液中。經常報導從 PVC 袋中浸出和提取鄰苯二甲酸二（2-乙基己酯）（DEHP），大部分 DEHP 用於儲存和輸送血液的地方，或用於親脂性藥物的腸內和腸外給藥。使用營養補充劑的地方。這阻礙了市場增長。

COVID-19 影響分析

COVID-19 的出現對全球輸液袋市場產生了相當大的影響。在大流行中，美國等發達國家經歷了液體和液體袋的短缺，迫使醫療機構和提供者推遲對患者的護理或採取其他替代方案，從而導致患者護理的減少。 FDA 等公共衛生當局經常要求製造商提高生產能力以解決這些短缺問題。在大流行期間，美國各州的 COVID-19 病例將增加，對恢復期血漿的需求將猛增。此外，隨著 COVID-19 患者數量的增加，對靜脈輸液的需求將增加。同時，主要公司擴大生產能力以滿足市場需求。例如，2020 年 4 月，百特和費森尤斯承諾向需要治療 COVID-19 患者的醫院提供額外的物資，例如腎透析機。在此，我們提議將含有袋裝乳酸透析液的預混透析液的產量提高 75%。百特還表示，它已經增加了許多其他用品的生產，例如迷你袋和藥物輸送系統。在大流行期間，輸液袋經歷了迅猛的市場增長。

全球輸液袋市場報告將提供對大約 80 多個市場數據表、70 多個圖表和 250 多個頁面（大約）的訪問。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型：市場細分
  • 按材料：市場細分
  • 按規模：市場細分
  • 按應用：市場細分
  • 按最終用戶：市場細分
  • 按地區：市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 感染增加
      • 老年人口增加
    • 限制
    • 用於靜脈滴注的塑料袋中流出的化學物質的風險
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 單室
  • 多室

第 8 章按材料分類

  • 乙烯醋酸乙烯酯
  • 聚丙烯
  • 聚氯乙烯
  • 其他

第 9 章按大小劃分

  • 0-250ml
  • 250-500ml
  • 500-1000ml

第 10 章按應用程序

  • 藥物遞送
  • 輸血
  • 血液儲存
  • 其他

第 11 章，最終用戶

  • 醫院
  • 水合設施/診所
  • 家庭醫療
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按治療類型劃分的基準

第 14 章公司簡介

  • 百特
    • 公司概況
    • 治療類型組合和描述
    • 主要亮點
    • 財務摘要
  • B. Braun Melsungen AG
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • JW Life Science
  • RENOLIT
  • PolyCine GmbH
  • Sealed Air
  • ANGIPLAST PVT. LTD
  • Shanghai Solve Care Co Ltd.
  • Kraton Corporation
  • Jiangxi Sanxin Medtec Co., Ltd.

第 15 章全球輸液袋市場-DataM

簡介目錄
Product Code: DMPH5857

Market Overview

IV Bags Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

The IV bags are used to deliver different clinical nutritional fluids such as sodium chloride or other parenteral nutrition to the patient's body to treat a specific disease such as chronic diseases. The patient's IV fluids for specific purposes include medication administration, fluid, and electrolyte replacement and balance maintenance, blood or blood product delivery, and nutrient and nutritional supplement delivery.

Market Dynamics

The IV bags market growth is driven by the rise in prevalence of different diseases such as cancer, and neurological disorders rising adoption of IV therapy to take proper treatment of diseases, the increase in the geriatric population, and research and development activities.

The rising adoption of parenteral nutrition therapy is expected to drive the market growth

The rising prevalence of different diseases such as cancer and cardiovascular diseases is expected to boost the market over the forecast period. According to the WHO 2022 data report, due to non-communicable diseases 41 million people are killed each year. The disease includes cancers, diabetes, and others. In this case, parenteral nutrition is needed in an emergency case. The rising incidence of diseases such as malignancy, ischemic gut malady, gastrointestinal disorders, Crohn's disease, and diabetic intricacies is propelled interest in parenteral nutrition. Increasing demand for parenteral nutrition therapy drives the IV bags market worldwide.

In addition, the key players are applying their market strategies such as new product launching and collaboration with other market players. For instance, In January 2022, ICU Medical acquire Smiths Medical from Smiths Group plc, this acquisition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products to the ICU Medical portfolio strengthen a leading infusion therapy company with a more strong worldwide reach. Also, in March 2021, Fagron Sterile Services (FSS) expanded its product portfolio by introducing a new platform with multiple presentations available for Intravenous (IV) Bags.

The leaching chemical from IV Bags will hamper the growth of the market

However, PVC bags are not suitable for everyone's formulations such as blood products. Mainly, Polyvinyl chloride (PVC) material is used for IV bags. PVC is not inherently flexible, plasticizers are added to achieve desirable properties. These plasticizers are not covalently bound to the PVC matrix and thus can easily leach into the surrounding solutions. The Leaching and extraction of di (2-ethylhexyl) phthalate (DEHP) from PVC bags have been reported often, with most DEHP found in bags utilized where blood is stored and delivered, or lipophilic drugs enteral and parenteral nutrition admixtures. This will hamper the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global IV bag market. In the pandemic, developed countries such as the United States have witnessed IV fluid and IV bag shortages, forcing healthcare facilities and providers to delay patient treatment or adopt other alternatives, resulting in a decrease in patient care. Public health authorities such as the FDA routinely request manufacturers to increase their ability to grow production capacity to address these shortages. In a pandemic, the United States is witness to a rapid rise in demand for convalescent plasma as COVID-19 cases increase in the states. The demand for IV fluid will increase with the increasing number of COVID-19 patients. On the other hand, the key players expanded their manufacturing production capabilities to meet the demand in the market. For instance, in April 2020, Baxter and Fresenius declared that they would deliver extra kidney dialysis equipment and other supplies to hospitals that require them for treating COVID-19 patients. In this, they provided a 75% increase in the production of premixed dialysate fluids with bagged lactate dialysate solution. Baxter also stated that it has increased the production of many other supplies, such as the mini-bag plus drug delivery system. The IV bags had positive market growth in the pandemic.

Segment Analysis

The multi-chamber IV bags segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The multi-chamber IV bag segment is expected to boost the market over the period of the forecast. Multi-chamber IV bags provide numerous benefits, including improved patient safety because they reduce handling and the risk of contamination. Patients can receive standard mixtures of fluids such as lipids, amino acids, or glucose. They have separate seals and can store more than one nutritional fluid. In April 2022, the article published in the Chinese Society for Parenteral and Enternal Nutrition, mentioned the advantages of Multi-chmaber IV bags for home and hospital use.

The multi-chamber bag preparation has a variety of specifications and has the characteristics of ready-to-use, strict quality standards, reasonable prescription, and other characteristics, which can decrease configuration and prescription errors, lower bloodstream infections, and meet the clinical nutritional needs of the patients. The key players offer the only multi-chamber IV bag product portfolio in the market. For instance, B. Braun offers multi-chamber IV bags such as 3-chamber IV bags for emulsion infusion for nutrition purposes and also offers dual chamber IV bags for the purpose of separate filling and storage of lipid emulsion until the mixing of the full solution just before administration to the patient. These bags are available in different sizes such as 50 ml, 100 ml, 500 ml, 1000 ml, and others.

Geographical Analysis

North America region holds the largest market share of the global IV bags market

North America dominates the market for IV bags and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to a rising elderly population with diseases such as cancer and respiratory diseases, an advanced healthcare system, and the presence of market players. Patients who are undergoing an operative process receive IVs that provide essential fluids like saline. To store these fluids requires IV bags.

The larger patient pool means more demand for IV bags in the region. In addition, the presence of competitors, acquisitions, and new product launches boosts the market growth in the North American region. For instance, in February 2022, B. Braun Medical Company received United States FDA approval to start operations at its new IV saline solution manufacturing facility in Florida, United States. It will address the shortage of IV fluids and is expected to manufacture 0.9% sodium chloride for injection.

Also in March 2021, Fagron Sterile Services US (FSS) expanded its product portfolio with a new platform - intravenous (IV) bags in the United States.

Competitive Landscape

The IV bags market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Baxter, B. Braun Melsungen AG, Pfizer, Inc., Fresenius Kabi AG, JW Life Science, RENOLIT, PolyCine GmbH, Sealed Air, ANGIPLAST PVT. LTD, Shanghai Solve Care Co Ltd., Kraton Corporation, and Jiangxi Sanxin Medtec Co., Ltd. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the IV bags market globally.

For instance,

  • In June 2022, Gufic Biosciences partnered with its French counterpart to manufacture new technology indigenously in India. The dual-chamber bags introduced by Gufic Biosciences were 2-Chamber IV Bags, made up of polypropylene (DEHP free) with a peelable aluminum foil allowing the storage of unstable drugs which require a reconstitution just before the administration to the patient.

Baxter Healthcare

Overview:

Baxter Healthcare is an American multinational healthcare company founded in 1940, headquartered in United States. It is provides the wide range of parenteral nutrition portfolio including vitamins and lipids, premix IV solutions, and pharmacy workflow management, labeling and compounding technology.

Treatment type Portfolio:

Baxter Sodium Chloride 0.9% IV Bags: It is available in variety of configurations and sizes such as 50mL, 100mL, 250mL, 500mL, and 1000mL Viaflex containers. These products are used for for intravenous administration. It is available in sodium chloride (0.9%), dextrose (5%) in water (D5W), and lactated ringers (LR).

The global IV bags market report would provide access to approximately 80+ market data tables, 70+ figures, and in the range of 250+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Type
  • 3.2. Market Snippet By Material
  • 3.3. Market Snippet By Size
  • 3.4. Market Snippet By Application
  • 3.5. Market Snippet By End User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising infectious disease
      • 4.1.1.2. The increasing geriatric population
    • 4.1.2. Restraints:
    • 4.1.3. Risk of leaching of chemicals from the plastic IV bags
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Single Chamber*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Multi-Chamber

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Ethylene Vinyl Acetate*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Polypropylene
  • 8.4. Polyvinyl Chloride
  • 8.5. Others

9. By Size

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size Segment
    • 9.1.2. Market Attractiveness Index, By Size Segment
  • 9.2. 0 - 250 ml*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. 250 - 500 ml
  • 9.4. 500 - 1000 ml

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 10.1.2. Market Attractiveness Index, By Application Segment
  • 10.2. Deliver Medications*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Blood Transfusions
  • 10.4. Blood Storage
  • 10.5. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Hydration Centers / Clinics
  • 11.4. Home Care Settings
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Size
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution channel

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Treatment type Benchmarking

14. Company Profiles

  • 14.1. Baxter*
    • 14.1.1. Company Overview
    • 14.1.2. Treatment type Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. B. Braun Melsungen AG
  • 14.3. Pfizer, Inc.
  • 14.4. Fresenius Kabi AG
  • 14.5. JW Life Science
  • 14.6. RENOLIT
  • 14.7. PolyCine GmbH
  • 14.8. Sealed Air
  • 14.9. ANGIPLAST PVT. LTD
  • 14.10. Shanghai Solve Care Co Ltd.
  • 14.11. Kraton Corporation
  • 14.12. Jiangxi Sanxin Medtec Co., Ltd.

LIST NOT EXHAUSTIVE

15. Global IV Bags market- DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us